在G1细胞周期停止期间,瘤原始细胞向有毒细胞过度生长发出瘤信号
Reece Foy1, Lisa Crozier1, Aanchal U Pareri1
1Cellular and Systems Medicine, Jacqui Wood Cancer Centre, School of Medicine, University of Dundee, Dundee DD1 9SY, UK.
Molecular cell
|November 17, 2023
概括
CDK4/6抑制剂在细胞周期停止期间利用癌细胞的过度生长. 这种合成致命性导致瘤细胞死亡,提供向的抗癌疗法,减少对健康组织的毒性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 循环素依赖性激酶4/6 (CDK4/6) 抑制剂是有效的抗癌药物.
- 这些药物诱导G1细胞周期停止和瘤细胞的衰老.
- 它们对瘤特异性毒性背后的确切机制尚不清楚.
研究的目的:
- 阐明CDK4/6抑制剂诱导瘤特异性毒性的机制.
- 研究CDK4/6抑制期间瘤信号和细胞生长的作用.
- 确定潜在的治疗策略,以提高CDK4/6抑制剂的疗效.
主要方法:
- 研究了CDK4/6抑制对具有瘤信号的瘤细胞的影响.
- 分析了细胞周期进展,细胞过度生长和DNA损伤.
- 研究了mTOR信号通路在调解CDK4/6抑制剂反应中的作用.
- 测试了调节瘤信号对癌细胞脆弱性的影响.
主要成果:
- 瘤细胞对CDK4/6抑制具有特殊的脆弱性,原因是G1停止期间导致有毒过度生长的瘤信号.
- 这种过度生长导致永久性细胞循环停止或基因毒性损伤.
- 抑制mTOR信号传递可以挽救癌细胞的过度生长和DNA损伤.
- 在正常细胞中诱导瘤信号使它们对CDK4/6抑制敏感.
结论:
- 细胞循环停止和瘤细胞生长的结合会产生一种合成致命的相互作用.
- CDK4/6抑制剂利用这种合成致命性来诱导瘤特异性毒性.
- 向瘤信号通路,特别是mTOR,可以提高CDK4/6抑制剂的治疗疗效.
相关概念视频
Cancer-Critical Genes I: Proto-oncogenes
8.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Cancers Originate from Somatic Mutations in a Single Cell
12.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.0K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K


